| ISIN | LU2552685112 | 
|---|---|
| Valor Number | 122824400 | 
| Bloomberg Global ID | UBSHEIX LX | 
| Fund Name | UBS (Lux) Equity SICAV - Global High Dividend (USD) (EUR hedged) I-X-acc | 
| Fund Provider | 
                                            
                                            
                                            UBS Asset Management Switzerland AG, Zurich
                                            
    
        8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds  | 
                                    
| Fund Provider | UBS Asset Management Switzerland AG, Zurich | 
| Representative in Switzerland | 
                                            UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10  | 
                                    
| Distributor(s) | 
                                            
                                                UBS Global Asset Management Basel Phone: +41 61 288 20 20  | 
                                    
| Asset Class | Equities | 
| EFC Category | Equity Global Advanced Markets | 
| Distribution Policy | Accumulation | 
| Home Country | Luxembourg | 
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) | 
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) | 
| Investment Strategy *** | UBS Asset Management categorises this sub-fund as a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests worldwide following the principle of risk diversification, with at least two thirds of its assets invested in equities or other equity interests of small, medium and large-cap companies in both developed and emerging markets. The Fund strategy is to select companies with high, consistent dividends. As the sub-fund invests in many foreign currencies due to its global orientation, the portfolio or parts thereof may be hedged against the reference currency of the sub-fund in order to reduce the associated foreign currency risks. | 
| Peculiarities | 
| Current Price * | 140.26 EUR | 31.10.2025 | 
|---|---|---|
| Previous Price * | 140.81 EUR | 30.10.2025 | 
| 52 Week High * | 141.27 EUR | 27.10.2025 | 
| 52 Week Low * | 114.67 EUR | 08.04.2025 | 
| NAV * | 140.26 EUR | 31.10.2025 | 
| Issue Price * | 140.26 EUR | 31.10.2025 | 
| Redemption Price * | 140.26 EUR | 31.10.2025 | 
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 861,945,598 | |
| Unit/Share Assets *** | 10,423,773 | |
| Trading Information SIX | ||
| YTD Performance | +10.70% | 
        31.12.2024 - 31.10.2025
        31.12.2024 31.10.2025  | 
                                    
|---|---|---|
| YTD Performance (in CHF) | +10.00% | 
        31.12.2024 - 31.10.2025
        31.12.2024 31.10.2025  | 
                                        
| 1 month | +1.70% | 
        30.09.2025 - 31.10.2025
        30.09.2025 31.10.2025  | 
                                    
| 3 months | +6.17% | 
        31.07.2025 - 31.10.2025
        31.07.2025 31.10.2025  | 
                                    
| 6 months | +12.57% | 
        30.04.2025 - 31.10.2025
        30.04.2025 31.10.2025  | 
                                    
| 1 year | +9.46% | 
        31.10.2024 - 31.10.2025
        31.10.2024 31.10.2025  | 
                                    
| 2 years | +39.77% | 
        31.10.2023 - 31.10.2025
        31.10.2023 31.10.2025  | 
                                    
| 3 years | +39.47% | 
        18.11.2022 - 31.10.2025
        18.11.2022 31.10.2025  | 
                                    
| 5 years | - | - | 
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AbbVie Inc | 1.10% | |
|---|---|---|
| Wiwynn Corp Ordinary Shares | 1.10% | |
| Johnson & Johnson | 1.07% | |
| Intesa Sanpaolo | 1.06% | |
| GSK PLC | 1.05% | |
| Pfizer Inc | 1.05% | |
| ING Groep NV | 1.04% | |
| BHP Group Ltd | 1.04% | |
| Generali | 1.04% | |
| Medtronic PLC | 1.04% | |
| Last data update | 30.09.2025 | |
| TER | 0.03% | 
|---|---|
| TER date | 31.05.2025 | 
| Performance Fee *** | 0.00% | 
| PTR | |
| Max. Management Fee *** | 0.00% | 
| Ongoing Charges *** | 0.03% | 
| 
                                            SRRI ***
                                             | 
                                    |
| SRRI date *** | |